Amrize (NYSE:AMRZ) Shares Gap Down After Earnings Miss

Amrize Ltd (NYSE:AMRZ) shares gapped down prior to trading on Friday after the company announced weaker than expected quarterly earnings. The stock had previously closed at $51.22, but opened at $47.50. Amrize shares last traded at $47.6760, with a volume of 1,364,674 shares traded.

The company reported $0.88 EPS for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The business had revenue of $3.49 billion during the quarter.

Amrize Cuts Dividend

The firm also recently announced a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is 21.05%.

Amrize News Roundup

Here are the key news stories impacting Amrize this week:

• Positive Sentiment: Amrize reported second-quarter revenue of $3.49 billion, up 8.6% year over year, while net income increased 14.4% to $476 million. Growth was supported by demand from data centers, energy projects, manufacturing plants and infrastructure modernization. Amrize Reports Second Quarter 2026 Results
• Positive Sentiment: The company raised its 2026 revenue outlook to $12.5 billion-$12.7 billion, above the roughly $12.4 billion analyst consensus, and forecast adjusted EBITDA of $3.1 billion-$3.2 billion. Amrize Lifts 2026 Revenue Outlook
• Positive Sentiment: Amrize declared a quarterly dividend of $0.11 per share, payable August 26, and returned $502 million to shareholders through dividends and share repurchases during the quarter. Amrize Declares Dividend
• Neutral Sentiment: Quarterly earnings grew from the prior year, with reported EPS of $0.88 versus $0.78 a year earlier, but the comparison includes differing estimates and reported diluted-EPS figures across company and data-provider disclosures.
• Negative Sentiment: Reported EPS of $0.88 missed the $0.92 consensus estimate, making the earnings shortfall the clearest near-term reason for investor disappointment. Amrize Misses Q2 Earnings Estimates
• Negative Sentiment: Higher fuel, freight and other operating costs limited adjusted EBITDA growth to 5.8% and pressured margins despite stronger sales, raising concerns about cost inflation and profit conversion.

Analysts Set New Price Targets

A number of analysts recently issued reports on the stock. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the stock an “overweight” rating in a research note on Monday, June 22nd. Royal Bank Of Canada reduced their price objective on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating on the stock in a research note on Friday, May 1st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Oppenheimer cut their target price on shares of Amrize from $68.00 to $65.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 21st. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $62.79.

Insider Transactions at Amrize

In other news, insider Nollaig Forrest purchased 2,000 shares of the company’s stock in a transaction that occurred on Friday, May 22nd. The shares were acquired at an average cost of $50.25 per share, with a total value of $100,500.00. Following the transaction, the insider owned 20,139 shares in the company, valued at approximately $1,011,984.75. The trade was a 11.03% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CTO Roald Brouwer acquired 1,500 shares of Amrize stock in a transaction that occurred on Thursday, May 21st. The shares were purchased at an average price of $49.84 per share, for a total transaction of $74,760.00. Following the completion of the purchase, the chief technology officer directly owned 19,757 shares of the company’s stock, valued at $984,688.88. The trade was a 8.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired a total of 54,918 shares of company stock valued at $2,717,324 over the last 90 days. Insiders own 0.54% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of AMRZ. Geode Capital Management LLC acquired a new stake in Amrize during the second quarter worth about $265,000. M&T Bank Corp acquired a new position in Amrize in the second quarter valued at approximately $205,000. Arrowstreet Capital Limited Partnership acquired a new position in Amrize in the second quarter valued at approximately $3,870,000. Gabelli Funds LLC acquired a new position in Amrize in the second quarter valued at approximately $1,083,000. Finally, AXA S.A. bought a new position in shares of Amrize during the second quarter valued at approximately $1,065,000.

Amrize Price Performance

The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The company has a fifty day moving average price of $52.09 and a 200 day moving average price of $54.78. The company has a market capitalization of $26.25 billion, a P/E ratio of 22.71, a price-to-earnings-growth ratio of 1.12 and a beta of 0.11.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.